TDK's corporate venturing unit is lining up more deals to go with its investment in Genetesis this week, having been formed early last year with one eye on an economic downturn.

The Covid-19 pandemic has not had a significant effect on TDK Ventures, the strategic investment arm of Japan-headquartered electronics manufacturer TDK, as it was formed with the expectation of an economic slowdown, managing director Nicolas Sauvage told Global Corporate Venturing. “We did anticipate a downturn when we presented the TDK Ventures project to the board…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.